Physician profile
Thomas P Davis
NPI 1184673303
$127,287.57
in general payments reported to CMS, 2019-2025
53 companies · $20K in 2025
The $20K reported for 2025 was more than what 96% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24K · 2020: $22K · 2021: $28K · 2022: $12K · 2023: $13K · 2024: $8,438 · 2025: $20K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $20K · Food and Beverage: $12K · Travel and Lodging: $3,709 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,250 · Honoraria: $2,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $20,168.75 |
| Food and Beverage | $11,970.81 |
| Travel and Lodging | $3,708.90 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,250.00 |
| Honoraria | $2,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $22,454.49 | 2019-2025 | Lutonix Drug Coated Balloon, Venclose Maven Catheter, Rotarexs 6 F X 135 Cm |
| Catheter Precision, INC. Fka Ra Medical Systems, INC. | $18,730.30 | 2019-2022 | |
| Cardiovascular Systems INC. | $12,842.05 | 2019-2022 | |
| Stryker Corporation | $12,200.78 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit, Clottriever Bold Catheter |
| Avinger INC. | $9,114.19 | 2019-2023 | Pantheris |
| Cordis US Corp. | $9,001.06 | 2021-2025 | Mynx Control, Brite Tip Radianz, Brite Tip |
| Intact Vascular, INC. | $8,300.74 | 2019 | |
| Siemens Medical Solutions USA, INC. | $7,852.45 | 2019-2022 | |
| Inari Medical, INC. | $5,735.12 | 2022-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Medtronic, INC. | $3,325.88 | 2021-2025 | Corevalve Evolut R, Symplicity G3, Apollotm |
| Cagent Vascular INC | $2,594.68 | 2025 | Serrantor |
| Philips North America LLC | $2,150.59 | 2019-2025 | (Bh4) Igt Devices Undivided, Igt Devices Systems Undivided, IV Other |
| Asahi Intecc Co., Ltd. | $2,000.00 | 2025 | |
| Boston Scientific Corporation | $1,168.66 | 2019-2025 | Emblem Mri S-Icd, General - Balloon Catheters, Varithena Administration Pack |
| Abbott Laboratories | $1,040.13 | 2019-2025 | Diamondback Peripheral, Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiva Medical, INC. | $896.40 | 2021-2025 | Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 5f Vcs |
| Ekos Corporation | $734.23 | 2019 | |
| Endologix LLC | $733.64 | 2019-2025 | Alto Abdominal Stent Graft System, Endocross Device, Torus Stent Graft System |
| Abiomed | $647.94 | 2022-2025 | Impella |
| Asahi Intecc USA, INC. | $503.48 | 2022-2024 | Peripheral Vascular |
| Janssen Pharmaceuticals, INC | $488.17 | 2019-2022 | |
| Medtronic Vascular, INC. | $475.59 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $415.11 | 2023-2025 | Lifevest |
| Kestra Medical Technology Services, INC. | $386.20 | 2022-2025 | Assure Wcd |
| Novartis Pharmaceuticals Corporation | $370.25 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $326.07 | 2021-2025 | Camzyos, Eliquis |
| Ablative Solutions, INC. | $284.44 | 2021-2022 | |
| Surmodics, INC. | $249.75 | 2024-2025 | Pounce Venous Thrombectomy System, Pounce Thrombectomy, Sublime 014 Rx Pta Balloon Dilatation Catheter |
| Cardinal Health 200 LLC | $249.54 | 2019-2021 | |
| Amgen INC. | $238.48 | 2020-2025 | Repatha, Repatha |
| Pfizer INC. | $227.39 | 2019-2024 | |
| Edwards Lifesciences Corporation | $226.59 | 2019-2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Becton, Dickinson and Company | $195.98 | 2020-2025 | Rotarexs 6 F X 135 Cm, Lutonix Drug Coated Balloon |
| Boehringer Ingelheim Pharmaceuticals, INC. | $180.07 | 2023-2025 | Jardiance |
| Venclose INC. | $164.45 | 2020 | |
| Angiodynamics, INC. | $148.11 | 2020-2025 | Auryon Laser System 100-120 Vac, Venacure 1470 Pro |
| Avantec Vascular Corporation | $109.80 | 2025 | |
| Kiniksa Pharmaceuticals, Ltd. | $83.43 | 2021-2022 | |
| Biosense Webster, INC. | $81.84 | 2023 | Carto 3 |
| Astrazeneca Pharmaceuticals Lp | $65.89 | 2020-2021 | |
| Veryan Medical Incorporated | $59.28 | 2021 | |
| Terumo Medical Corporation | $41.06 | 2021 | |
| Reflow Medical INC | $38.28 | 2023 | |
| Novo Nordisk INC | $38.12 | 2019-2024 | Wegovy |
| Kiniksa Pharmaceuticals International, Plc | $31.15 | 2024 | Arcalyst |
| Cook Medical LLC | $22.39 | 2020 | |
| Imperative Care, INC | $16.80 | 2019 | |
| Merck Sharp & Dohme LLC | $15.79 | 2021 | |
| Baxter Healthcare | $15.50 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Bsn Medical INC | $15.24 | 2022 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$581,820.34 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.